✦ LIBER ✦

Dexamethasone, etoposide, ifosfamide, and cisplatin as second-line therapy in patients with aggressive non-hodgkin's lymphoma

✍ Scribed by Nissim Haim; Menachem Ben-Shahar; David Faraggi; Avital Tsuri-Etzioni; Michelle Leviov; Ron Epelbaum

Publisher: John Wiley and Sons
Year: 1997
Tongue: English
Weight: 85 KB
Volume: 80
Category: Article
ISSN: 0008-543X
DOI: 10.1002/(sici)1097-0142(19971115)80:10<1989::aid-cncr17>3.0.co;2-u

No coin nor oath required. For personal study only.

✦ Synopsis

BACKGROUND.

This study analyzed the long term results of a combination of dexa-

📜 SIMILAR VOLUMES

Human immunodeficiency virus-related non

Human immunodeficiency virus-related non-Hodgkin lymphoma : Activity of infusional cyclophosphamide, doxorubicin, and etoposide as second-line chemotherapy in 40 patients

✍ Michele Spina; Emanuela Vaccher; Senka Juzbasic; Isabella Milan; Guglielmo Nasti 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB 👁 1 views

## Background: The prognosis of patients with human immunodeficiency virus (hiv)-related non-hodgkin lymphoma (nhl) is poor. in fact, despite a high complete response (cr) rate, approximately 50% of these patients die from progressive lymphoma. ## Methods: From november 1994 to april 2000, the au

Second-line chemotherapy in human immuno

Second-line chemotherapy in human immunodeficiency virus-related non-Hodgkin's lymphoma: Evidence of activity of a combination of etoposide, mitoxantrone, and prednimustine in relapsed patients

✍ Umberto Tirelli; Domenico Errante; Michele Spina; Roberta Gastaldi; Ezio Nigra; 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 432 KB 👁 1 views

## BACKGROUND. There is very little experience reported in the literature on the treatment of patients with relapsed or resistant human immunodeficiency virus-related non-Hodgkin's lymphoma (HIV-NIIL). We performed a prospective study to ovaluate the feasibility and activity of a second-line chemo